Long-acting antipsychotic medications

Raman Baweja, Karim Sedky, Steven Lippmann

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Antipsychotic medicines are the cornerstone pharmacotherapy for patients with psychotic disorders. Early and continuous management of psychoses improves the quality of life, decreases hospitalization and reduces medical costs. However, many psychotic patients are not fully compliant with treatment, and thus they more often experience a relapsing course with a suboptimal clinical outcome. Long-term parenteral antipsychotic agents may improve compliance by offering clear evidence of medication non-compliance and documented drug administration monitoring. Using injection therapy might be especially beneficial to poorly compliant individuals with their first-psychotic episode and those with severe psychopathology or comorbid substance abuse. The availability of five different antipsychotic drug depot medications offers diverse treatment options which can be individualized for each case.

Original languageEnglish (US)
Pages (from-to)555-560
Number of pages6
JournalCurrent Drug Targets
Volume13
Issue number4
DOIs
StatePublished - Apr 1 2012

Fingerprint

Antipsychotic Agents
Psychotic Disorders
Drug therapy
Medication Adherence
Drug Monitoring
Psychopathology
Compliance
Medicine
Substance-Related Disorders
Hospitalization
Therapeutics
Quality of Life
Availability
Costs and Cost Analysis
Drug Therapy
Injections
Monitoring
Pharmaceutical Preparations
Costs

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Baweja, Raman ; Sedky, Karim ; Lippmann, Steven. / Long-acting antipsychotic medications. In: Current Drug Targets. 2012 ; Vol. 13, No. 4. pp. 555-560.
@article{bd8a5c98598e4374bfa7f6e03dc06675,
title = "Long-acting antipsychotic medications",
abstract = "Antipsychotic medicines are the cornerstone pharmacotherapy for patients with psychotic disorders. Early and continuous management of psychoses improves the quality of life, decreases hospitalization and reduces medical costs. However, many psychotic patients are not fully compliant with treatment, and thus they more often experience a relapsing course with a suboptimal clinical outcome. Long-term parenteral antipsychotic agents may improve compliance by offering clear evidence of medication non-compliance and documented drug administration monitoring. Using injection therapy might be especially beneficial to poorly compliant individuals with their first-psychotic episode and those with severe psychopathology or comorbid substance abuse. The availability of five different antipsychotic drug depot medications offers diverse treatment options which can be individualized for each case.",
author = "Raman Baweja and Karim Sedky and Steven Lippmann",
year = "2012",
month = "4",
day = "1",
doi = "10.2174/138945012799499785",
language = "English (US)",
volume = "13",
pages = "555--560",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "4",

}

Long-acting antipsychotic medications. / Baweja, Raman; Sedky, Karim; Lippmann, Steven.

In: Current Drug Targets, Vol. 13, No. 4, 01.04.2012, p. 555-560.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Long-acting antipsychotic medications

AU - Baweja, Raman

AU - Sedky, Karim

AU - Lippmann, Steven

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Antipsychotic medicines are the cornerstone pharmacotherapy for patients with psychotic disorders. Early and continuous management of psychoses improves the quality of life, decreases hospitalization and reduces medical costs. However, many psychotic patients are not fully compliant with treatment, and thus they more often experience a relapsing course with a suboptimal clinical outcome. Long-term parenteral antipsychotic agents may improve compliance by offering clear evidence of medication non-compliance and documented drug administration monitoring. Using injection therapy might be especially beneficial to poorly compliant individuals with their first-psychotic episode and those with severe psychopathology or comorbid substance abuse. The availability of five different antipsychotic drug depot medications offers diverse treatment options which can be individualized for each case.

AB - Antipsychotic medicines are the cornerstone pharmacotherapy for patients with psychotic disorders. Early and continuous management of psychoses improves the quality of life, decreases hospitalization and reduces medical costs. However, many psychotic patients are not fully compliant with treatment, and thus they more often experience a relapsing course with a suboptimal clinical outcome. Long-term parenteral antipsychotic agents may improve compliance by offering clear evidence of medication non-compliance and documented drug administration monitoring. Using injection therapy might be especially beneficial to poorly compliant individuals with their first-psychotic episode and those with severe psychopathology or comorbid substance abuse. The availability of five different antipsychotic drug depot medications offers diverse treatment options which can be individualized for each case.

UR - http://www.scopus.com/inward/record.url?scp=84857772222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857772222&partnerID=8YFLogxK

U2 - 10.2174/138945012799499785

DO - 10.2174/138945012799499785

M3 - Article

C2 - 22250654

AN - SCOPUS:84857772222

VL - 13

SP - 555

EP - 560

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 4

ER -